Long-term extended-interval teclistamab and talquetamab dosing without step-up dosing in previously treated multiple myeloma.
Authors: Brooks C, Mader L, Kennedy K, Naing PT, Sengsayadeth S, Dholaria B, Kassim A, Profitt S, Baljevic M
Journal: Experimental hematology & oncology
group therapy
mental health
open access